MAPT and early-onset autosomal dominant Alzheimer disease: The researchers successfully achieved the dephosphorylation of tau protein with PhosTAC and confirmed that this approach can reduce the pathogenic pathological properties of tau protein, laying a foundation for the future treatment of Alzheimer’s disease [205,206,207].